Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.
Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей
Mohammadreza Khanmohammadi*
Despite a great deal latest development, prostate most cancers keep to symbolize a primary reason of most cancers-associated mortality and morbidity in men. Since early research at the function of the androgen receptor that caused the appearance of androgen deprivation remedy with inside the 1940s, there has lengthy been in depth hobby with inside the simple mechanisms underlying prostate most cancers initiation and progression, in addition to the capability to goal those strategies for healing intervention. Here, we gift an outline of predominant issues in prostate most cancers studies that specialize in present day information of important occasions in most cancers initiation and progression. We talk latest advances, consisting of new insights into the mechanisms of castration resistance, identity of stem cells and tumor-starting up cells, and improvement of mouse fashions for preclinical assessment of novel therapeutics. Overall, we spotlight the superb studies development made in latest years, and underscore the demanding situations that lie ahead.